Insulet Announces CE Mark Approval of Omnipod 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor
07.02.2024 - Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced it has received CE mark approval under the European Medical Device Regulation for ... Seite 1
Source: wallstreet-online.de